VanEck Pharmaceutical ETF (PPH) Short Interest Ratio & Short Volume → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free PPH Stock Alerts $90.23 -0.01 (-0.01%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share Short InterestStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial MediaStock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestSocial Media VanEck Pharmaceutical ETF Short Interest DataCurrent Short Volume1,440,000 sharesPrevious Short Volume1,400,000 sharesChange Vs. Previous Month+2.86%Dollar Volume Sold Short$126.09 millionShort Interest Ratio / Days to Cover9.5Last Record DateApril 30, 2024Outstanding Shares5,940,000 sharesPercentage of Shares Shorted24.24%Today's Trading Volume24,900 sharesAverage Trading Volume137,760 sharesToday's Volume Vs. Average18% Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPPH Short Interest Over TimePPH Days to Cover Over TimePPH Percentage of Float Shorted Over Time Ad The Freeport SocietyBiden Nomination CANCELED?The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.” Why is he all BUT guaranteed the Democratic nomination, in their words?I believe I have the terrifying answer right here. VanEck Pharmaceutical ETF Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20241,440,000 shares $126.09 million +2.9%N/A9.5 $87.56 4/15/20241,400,000 shares $119.62 million -11.4%N/A11.3 $85.44 3/31/20248,700 shares $789,090.00 -99.5%N/A0.1 $90.70 3/15/20241,570,000 shares $140.59 million -8.7%N/A13 $89.55 2/29/20241,720,000 shares $152.74 million +5.5%N/A14.9 $88.80 2/15/20241,630,000 shares $144.16 million -22.4%N/A14.9 $88.44Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… 1/31/20242,100,000 shares $179.13 million -0.5%N/A18.6 $85.30 1/15/20242,110,000 shares $180.57 million +14.7%N/A19.3 $85.58 12/31/20231,840,000 shares $149.71 million -4.7%N/A16.5 $81.37 12/15/20231,930,000 shares $152.10 million -18.9%N/A18 $78.81 11/30/20232,380,000 shares $186.85 million -1.2%N/A21.7 $78.51 11/15/20232,410,000 shares $184.75 million +4.3%N/A20.9 $76.66 10/31/20232,310,000 shares $173.97 million +4.5%N/A18.7 $75.31 10/15/20232,210,000 shares $177.00 million -1.3%N/A17.3 $80.09 9/30/20232,240,000 shares $178.89 million -1.3%N/A17.2 $79.86 9/15/20232,270,000 shares $186.03 million -2.6%N/A16.7 $81.95 8/31/20232,330,000 shares $190.83 million +16.5%N/A17.2 $81.90 8/15/20232,000,000 shares $165.46 million -17.0%N/A15.6 $82.73 7/31/20232,410,000 shares $193.81 million -0.4%N/A19.2 $80.42 7/15/20232,420,000 shares $188.49 million +5.2%N/A20.7 $77.89 6/30/20232,300,000 shares $181.17 million +0.4%N/A20.1 $78.77 6/15/20232,290,000 shares $179.70 million +19.9%N/A21.6 $78.47 5/31/20231,910,000 shares $144.49 million -12.8%N/A16.6 $75.65 5/15/20232,190,000 shares $172.48 million -10.3%N/A16.7 $78.76 4/30/20232,440,000 shares $192.44 million +1.2%N/A17.7 $78.87 4/15/20232,410,000 shares $191.59 million +3.9%N/A14.3 $79.50 3/31/20232,320,000 shares $180.10 million +19.0%N/A14.4 $77.63 3/15/20231,950,000 shares $144.65 million -18.8%N/A12.1 $74.18 2/28/20232,400,000 shares $181.56 million +8.1%N/A15.1 $75.65 2/15/20232,220,000 shares $173.74 million -7.5%N/A15.4 $78.26 1/31/20232,400,000 shares $188.02 million -0.4%N/A16.8 $78.34 1/15/20232,410,000 shares $191.60 million +4.8%N/A17.1 $79.50 12/30/20222,300,000 shares $178.80 million -3.8%N/A18.4 $77.74 12/15/20222,390,000 shares $186.68 million +7.2%N/A16 $78.11 11/30/20222,230,000 shares $171.78 million +10.4%N/A14.5 $77.03 11/15/20222,020,000 shares $147.97 million +27.9%N/A12.5 $73.25 10/31/20221,580,000 shares $115.10 million +6.8%N/A10.1 $72.85 10/15/20221,480,000 shares $101.05 million No ChangeN/A8.8 $68.28 9/30/20222,150,000 shares $144.57 million +4.9%N/A13 $67.24 9/15/20222,050,000 shares $144.94 million -10.1%N/A13 $70.70Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now PPH Short Interest - Frequently Asked Questions What is VanEck Pharmaceutical ETF's current short interest? Short interest is the volume of VanEck Pharmaceutical ETF shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 1,440,000 shares of PPH short. Learn More on VanEck Pharmaceutical ETF's current short interest. What is a good short interest ratio for VanEck Pharmaceutical ETF? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PPH shares currently have a short interest ratio of 10.0. Learn More on VanEck Pharmaceutical ETF's short interest ratio. Is VanEck Pharmaceutical ETF's short interest increasing or decreasing? VanEck Pharmaceutical ETF saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 1,440,000 shares, an increase of 2.9% from the previous total of 1,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does VanEck Pharmaceutical ETF's short interest compare to its competitors? Here is how the short interest of companies compare to VanEck Pharmaceutical ETF: VanEck Biotech ETF (0.08%), Invesco S&P SmallCap Health Care ETF (0.03%), ProShares Ultra Nasdaq Biotechnology (0.99%), Principal Healthcare Innovators ETF (0.36%), Invesco Nasdaq Biotechnology ETF (1.30%), First Trust Nasdaq Pharmaceuticals ETF (0.13%), JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (8.82%), and iShares Biotechnology ETF (16.51%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short VanEck Pharmaceutical ETF stock? Short selling PPH is an investing strategy that aims to generate trading profit from VanEck Pharmaceutical ETF as its price is falling. PPH shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against VanEck Pharmaceutical ETF? A short squeeze for VanEck Pharmaceutical ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PPH, which in turn drives the price of the stock up even further. How often is VanEck Pharmaceutical ETF's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PPH, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BBH Short Interest Data PSCH Short Interest Data BIB Short Interest Data BTEC Short Interest Data IBBQ Short Interest Data FTXH Short Interest Data JDOC Short Interest Data BIS Short Interest Data IBB Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PPH) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyUrgent Nvidia WarningAltimetryElon’s New Device is About to Shock the WorldInvestorPlace"The Biggest Drug Ever" Is ComingBehind the MarketsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders